News on GlaxoSmithKline (Ticker: GSK) continually updated from thousands of sources around the net.
12 hrs ago | Common Dreams
An experimental anti-malaria vaccine manufactured by pharmaceutical giant GlaxoSmithKline has shown promise at preventing the mosquito-born disease among children and infants, a new study finds.
16 hrs ago | Seeking Alpha
VBI Vaccines: A Company Ready for Breakthrough A company that I have been accumulating shares in is VBI Vaccines .
21 hrs ago | BioSpace
Tanzeum, a glucagon-like peptide-1 receptor agonist, is a once weekly option for patients, in combination with some other glucose-lowering medicines.
22 hrs ago | Live Charts
The stock market gave a warm reaction to Barclays' first-half results on Wednesday, with analysts upbeat about the bank's better-than-expected results.
Estimating future sales of these drugs is extremely difficult and we will see how analysts have developed their models and some of the points they are likely to miss.
During the past week, GuruFocus recognized four companies as dividend growers. In order to be qualified for this list, the company had to: The following four companies come from various industries and sectors of the market, but they all fit the necessary criteria needed to qualify them as dividend growers.
GlaxoSmithKline's fat dividend is under strain but Britain's biggest drugmaker is likely to scrape by without cutting payouts as it seeks to compensate investors during a bumpy reshaping of the company.
Following new developments related to the conduct of two representatives in China, GSK was hit with four bearish brokerage notes, including a downgrade to "sell" from "buy" at Liberum, and price-target cuts at Barclays, Berenberg, and Morgan Stanley.
Two foreign investigators tied to U.K. drug company GlaxoSmithKline PLC will stand trial Aug. 8 on charges of illegally purchasing personal information about Chinese nationals, a Chinese court said.
Haley Wilson, a rising senior at KIPP DuBois Collegiate Academy, is spending days this summer in the law department at GlaxoSmithKline learning about patents, trademarks and what it takes to bring a new medicine to market.
Britain's FTSE 100 index is seen opening higher on Monday, with September futures up 0.4 percent at 0625 GMT.
Note: We do not store your email address but your IP address will be logged to prevent abuse of this feature.
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
British drug giant GlaxoSmithKline may spin off its consumer health division as it tries to get to grips with increasing competition for its drugs and Chinese bribery allegations, it was reported on Monday.
Investors dumped shares of Theravance last week, sending the stock down 18% to $22.94, after GlaxoSmithKline, which distributes Theravance's flagship pulmonary-disorder treatments, reported that sales of the products fell dramatically below expectations in the latest quarter.
Updated: Wed Jul 30, 2014 04:07 pm
Copyright © 2014 Topix LLC